Trial record 1 of 1 for:    NCT00220415
Previous Study | Return to List | Next Study

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

This study has been completed.
Sponsor:
Information provided by:
UCB, Inc.
ClinicalTrials.gov Identifier:
NCT00220415
First received: August 30, 2005
Last updated: August 26, 2014
Last verified: February 2010